Intellipharmaceutics to Present at the LD Micro Main Event
24 nov. 2015 12h00 HE
|
Intellipharmaceutics International Inc.
TORONTO, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics to Present at The MicroCap Conference
27 oct. 2015 06h15 HE
|
Intellipharmaceutics International Inc.
TORONTO, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics to Present at Dawson James Securities Growth Stock Conference
09 oct. 2015 07h00 HE
|
Intellipharmaceutics International Inc.
TORONTO, Oct. 9, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Announces Third Quarter 2015 Results
09 oct. 2015 07h00 HE
|
Intellipharmaceutics International Inc.
TORONTO, Oct. 9, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Updates Status of Tentative Approvals of Generic Focalin XR(R)
05 août 2015 08h15 HE
|
Intellipharmaceutics International Inc.
TORONTO, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Announces Second Quarter 2015 Results
13 juil. 2015 07h30 HE
|
Intellipharmaceutics International Inc.
TORONTO, July 13, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Updates Status of Tentative Approvals of Generic Focalin XR(R)
08 juil. 2015 18h20 HE
|
Intellipharmaceutics International Inc.
TORONTO, July 8, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Updates Status of Tentative Approvals of Generic Focalin XR(R)
18 juin 2015 17h30 HE
|
Intellipharmaceutics International Inc.
TORONTO, June 18, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
FDA Grants Fast Track Designation for Intellipharmaceutics Rexista(TM) Oxycodone XR Incorporating PODRAS(TM) Technology
26 mai 2015 08h00 HE
|
Intellipharmaceutics International Inc.
TORONTO, May 26, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Announces Agreement to Acquire Real Property that Houses its Manufacturing, R&D and Office Facilities in Toronto, Ontario and Status of 5mg Strength of its Generic Focalin XR(R)
25 mai 2015 20h50 HE
|
Intellipharmaceutics International Inc.
TORONTO, May 25, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...